Acquisition Opportunity Asolva was acquired by Harris Corporation in March 2023, signaling a strategic expansion of antimicrobial stewardship capabilities. This suggests potential cross-sell opportunities within Harris' client base and alignment with enterprise IT and healthcare software adoption.

Healthcare Focus Specialized in clinical analytics software for hospitals of all sizes, with a focus on antimicrobial resistance. This indicates a market need for scalable analytics solutions in healthcare settings, presenting opportunities to expand with hospitals looking to optimize stewardship programs and patient outcomes.

Compliance & Validation A history of collaboration with the CDC to refine validation processes, highlighting strength in regulatory alignment and vendor credibility. Target prospects prioritizing validated analytics and compliance-ready solutions could be receptive to Asolva’s offerings.

Low Revenue, High Value Current revenue under one million dollars with a lean team. This suggests ripe opportunities for strategic partnerships or channel/affiliate models to accelerate growth, especially with reference accounts from Harris and CDC-aligned programs.

Tech Stack & Visibility Utilizes widely adopted tools (WordPress, Google Cloud, SEO, analytics) indicating a modern, cloud-based deployment model. This can ease discussions around integration, data security, and scalable deployment for hospital IT environments.